Product Information

CHEST CONG RLF DM 400-20 MG TB is a generic product labeled by Cardinal Health, priced at $0.0828 per EA under NDC 70000005601. Its NADAC has been published 267 times since Oct 6, 2021.

CHEST CONG RLF DM 400-20 MG TB

Dextromethorphan Hydrobromide / Guaifenesin
$0.0828per EA
OTC

Strength

20; 400 mg/1; mg/1

Manufacturer

Cardinal Health

NDC

70000005601

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

9/1/2020

Pharmacological Classes

Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists

Price Statistics

The NADAC for CHEST CONG RLF DM 400-20 MG TB has been published 267 times since Oct 6, 2021, and over the history we have for it it has risen 4.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0828 per EA
All-time high$0.0831 (Sep 11, 2024)
All-time low$0.0720 (May 18, 2022)
52-week high$0.0828
52-week low$0.0779
Median price$0.0787
Average price$0.0785
Largest weekly change+13.7% (Jun 22, 2022)
Weeks tracked267
Tracking sinceOct 6, 2021

Price History

1W

0.0%

1M

+1.1%

3M

+4.9%

6M

+4.1%

1Y

+5.0%

3Y

+5.8%

5Y

+8.8%

All

+4.5%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CHEST CONG RLF DM 400-20 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for CHEST CONG RLF DM 400-20 MG TB, manufactured by Cardinal Health, is $0.0828 per EA (NDC 70000005601), effective Nov 11, 2026.

How has the price of CHEST CONG RLF DM 400-20 MG TB changed over time?

Over the history we have for it, the NADAC for CHEST CONG RLF DM 400-20 MG TB has risen 4.5%. It has been tracked across 267 weekly CMS publications since Oct 6, 2021.

What are the highest and lowest recorded NADAC prices for CHEST CONG RLF DM 400-20 MG TB?

Since Oct 6, 2021, the NADAC for CHEST CONG RLF DM 400-20 MG TB has ranged from a low of $0.0720 (May 18, 2022) to a high of $0.0831 (Sep 11, 2024), with a median of $0.0787 per EA.

Are there cheaper alternatives to CHEST CONG RLF DM 400-20 MG TB?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC MUCUS RELIEF DM TABLET, is $0.0766 per EA — about 8% below CHEST CONG RLF DM 400-20 MG TB.

Who manufactures CHEST CONG RLF DM 400-20 MG TB?

CHEST CONG RLF DM 400-20 MG TB (NDC 70000005601) is labeled by Cardinal Health, and CMS classifies it as a generic product.